Italy-based Bracco Imaging and Subtle Medical have obtained an EU CE mark for AiMIFY, a jointly developed software designed to enhance the imaging of contrast MRI brain scans using artificial ...
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
In the U.S., Elucirem is indicated in adults and now in pediatric patients including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal ...
Ferabright is the first and only iron-based contrast agent for MRI in the brainWoburn, MA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that FerabrightTM ...
Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with the highest relaxivity, in comparison to other availab ...
Scientists can label cells with bioluminescent probes—proteins that glow—making it possible to track the growth of a tumor, or measure changes in gene expression that occur as cells differentiate.
Objectives Acute anterior ischaemic optic neuropathy (AION) is a feared ischaemic complication of giant cell arteritis (GCA).
"Together with thorough clinical/neuropsychological investigations, brain MRI may represent a key tool for exploring the structural abnormalities that are typical of subjects with APS… earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results